Has Alison Smoller received payments from drug or device companies?

Yes. Drug and device makers reported $2,338 in general payments to Alison Smoller across 231 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Alison Smoller did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Alison Smoller come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Alison Smoller

Developmental - Behavioral Pediatrics · New York, NYNPI 1730384884

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.7% of the total across 231 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Neos Therapeutics, LP at 27.7% of the total. Reporting peaked in 2022 at $929 and has fallen 95.2% since, to $45 in 2025. Among developmental - behavioral pediatrics clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,338in general payments, 2019–2025

Across 231 payments — averaging $10.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Neos Therapeutics, LP$647
Supernus Pharmaceuticals, Inc.$625
Corium, LLC$535
Tris Pharma Inc$216
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$58
Ironshore Pharmaceuticals Inc.$54
plus $203 from 9 others

What the payments were for

Food & beverage$2,331100%
Education$70%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Neos Therapeutics, LP	74	$647
Supernus Pharmaceuticals, Inc.	66	$625
Corium, LLC	51	$535
Tris Pharma Inc	17	$216
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	4	$58
Ironshore Pharmaceuticals Inc.	4	$54
Takeda Pharmaceuticals U.S.A., Inc.	3	$41
Adlon Therapeutics L.p.	3	$36
Teva Pharmaceuticals USA, Inc.	2	$30
Otsuka America Pharmaceutical, Inc.	2	$28
Rhodes Pharmaceuticals L.p.	1	$15
Vertical Pharmaceuticals, LLC	1	$14
Vanda Pharmaceuticals Inc.	1	$14
Merck	1	$14
Johnson & Johnson	1	$11

How this compares

$2,338 in reported general payments places this provider in the 90th percentile of 28 developmental - behavioral pediatrics providers in New York.

See all developmental - behavioral pediatrics providers in New York →

Other developmental - behavioral pediatrics in New York

Angela ChanNew York$198
Hyoryung Ann LeeNew York$179
Nydia Hernandez SantanaNew York$86
Stephen SulkesRochester$8K
Marci SilvermanWest Islip$3K
Laura KatzValhalla$2K
Glenn BelkinValhalla$2K
Jamie SklarBabylon$2K
Michele Alexandra LedesmaValhalla$1K
Anthony MaloneLatham$999

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →